NANO-X IMAGING LTD Ordinary Shares (NNOX)
Nano-X Imaging Ltd is a medical imaging company that develops and commercializes advanced digital X-ray systems. Known for its proprietary Nanox.ARC platform, the company aims to provide affordable, high-quality imaging solutions globally, particularly in underserved healthcare markets. Nano-X focuses on innovative technology to transform medical imaging and improve patient care accessibility.
Company News
Nanox is collaborating with Monarch Medical Management to deploy advanced medical imaging solutions across workers' compensation, nursing homes, and outpatient clinics, with plans to establish a comprehensive imaging network nationwide.
Nano-X Imaging, an Israeli X-ray imaging company, received FDA clearance for its Nanox.ARC X technology to produce 3D X-ray images. The company aims to disrupt the medical devices market by charging per X-ray delivered rather than selling X-ray machines. However, Nano-X is currently unprofitable and must demonstrate demand for its services to justify its valuation.
Here is how Nano-X Imaging Ltd. (NNOX) and Seagate (STX) have performed compared to their sector so far this year.
Trading in bullish options contracts tied to two small-cap companies owned by chipmaker Nvidia Corp. surged last week just days before the company released a routine filing.
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell 1% to 15,617.93. The S&P 500 also fell, dropping, 0.55% to 4,977.99. Check This Out: Top 4 Tech Stocks That May Crash This Month  Leading and Lagging Sectors  Consumer staples shares rose by 1.3% on Tuesday. In trading on Tuesday, consumer discretionary shares fell by 1%.  Top Headline  Capital One Financial Corp (NYSE: COF) has announced its plans to purchase Discover Financial Services (NYSE: DFS), marking a pivotal $35.3 billion all-stock transaction.  Equities Trading UP  Monopar Therapeutics Inc. (NASDAQ: MNPR) shares shot up 258% to $1.22. Monopar received clearance to proceed with first-in-human Phase 1 trial of novel radiopharmaceutical MNPR-101-Zr in advanced cancers. Shares of AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) got a boost, surging 181% ...